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Abstract 
 
Background 
Radiotherapy-induced DNA double strand breaks (DSB) are critical cytotoxic lesions. 
Inherited defects in DSB DNA repair pathways lead to hypersensitivity to ionising 
radiation, immunodeficiency and increased cancer incidence. A patient with xeroderma 
pigmentosum complementation group C, with a scalp angiosarcoma exhibited dramatic 
clinical radiosensitivity following radiotherapy, resulting in death. A fibroblast cell line 
from non-affected skin (XP14BRneo17) was hypersensitive to ionising radiation and 
defective in DNA double strand break repair.  
Aim 
To determine the genetic defect causing cellular radiation hypersensitivity in 
XP14BRneo17 cells. 
Methods 
Functional genetic complementation whereby copies of human chromosomes containing 
genes involved in DNA DSB repair (chromosomes 2, 5, 8 10, 13 and 22) were 
individually transferred to XP14BRneo17 cells in an attempt to correct the radiation 
hypersensitivity. Clonogenic survival assays and γ-H2AX immunofluorescence were 
conducted to measure radiation sensitivity and repair of DNA DSBs. DNA sequencing of 
defective DNA repair genes was performed. 
Results 
Transfer of chromosome 8 (location of DNA-PKcs gene), and transfection of a 
mammalian expression construct containing the DNA-PKcs cDNA restored normal 
ionising radiation sensitivity and repair of DNA DSBs in XP14BRneo17 cells. DNA 
sequencing of the DNA-PKcs coding region revealed a 249 bp deletion (between base 
pairs 3656-3904) encompassing exon 31 of the gene.  
Conclusion 
We provide evidence of a novel splice variant of the DNA-PKcs gene associated with 
radiosensitivity in a xeroderma pigmentosum patient and report the first double mutant in 
distinct DNA repair pathways being consistent with viability. 
 
Key words 
Functional complementation, radiosensitivity, DNA repair, DNA-PKcs gene, pre-mRNA 
splicing.
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Introduction 
Anticancer radiotherapy (RT) protocols exert cytotoxicity by inducing DNA damage, 
predominantly DNA double strand breaks (DSBs). Human cells possess enzymatic DNA 
repair systems which monitor and repair such damage and the efficacy of DNA repair has 
a significant impact on the success of RT1. In mammalian cells, two distinct biochemical 
pathways are responsible for repairing DSBs, homologous recombination (HR) and non-
homologous end joining (NHEJ).2 NHEJ is the predominant repair pathway whereby the 
DNA dependent protein kinase heterodimer containing the Ku80 / Ku70 complex binds 
to DNA ends and recruits DNA dependent protein kinase catalytic subunit (DNA-PKcs) 
and its substrate, the Artemis nuclease which prepares DNA ends for ligation. Ligation is 
mediated by a protein complex containing DNA ligase IV stabilised and stimulated by 
XRCC4 and Cernunos-XLF.3 Animal models demonstrate that defects in any component 
of NHEJ can lead to hypersensitivity to ionising radiation (IR), genome instability, 
immunodeficiency and cancer.4 In humans, defects in the specific genetic components of 
NHEJ also result in predisposition to lymphoma and leukaemia or to extreme 
radiosensitivity during RT.5-6 
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease characterised 
by sensitivity to sunlight and susceptibility to skin cancers.7 There are seven XP 
complementation groups (A-G) which define defects in nucleotide excision repair (NER), 
responsible for excising ultraviolet (UV) induced DNA photodamage.8 Although cells 
from XP patients are not typically sensitive to IR, cellular radiosensitivity has been 
reported in fibroblasts from an XPG patient and in an XPC patient.9-10 The XPC patient 
with a truncation in the carboxy terminus of the XPC protein presented with an 
angiosarcoma of the scalp which was treated by surgical excision and RT.11 Following 38 
Gy in 19 fractions with 6 MeV electrons, a severe scalp desquamation occurred 
associated with necrosis of the underlying bone, intracranial oedema and death. 
A primary fibroblast cell line (XP14BR) and an SV40-transformed derivative cell 
line (XP14BRneo17) from this patient were hypersensitive to the lethal effects of IR and 
UV consistent with the clinical phenotype.11 Transfection with the XPC cDNA restored a 
normal UV cytotoxic response but IR sensitivity was unchanged. XP14BR fibroblasts 
were distinguishable from radiosensitive ataxia telangiectasia cells (A-T) by virtue of a 
normal inhibition of DNA synthesis following IR exposure. Repair of radiation-induced 
DNA DSBs in XP14BR cells was significantly reduced when compared to normal 
fibroblast cell lines.11 XP14BR fibroblasts were not sensitive to the lethal effects of the 
DNA interstrand crosslinking (ICL) agents mitomycin C or nitrogen mustard (HN2) 
indicating that these cells were not defective in HR which plays an important role in 
regulating ICL cytotoxicity.12 
In this paper we present evidence, from microcell mediated chromosome transfer 
(MMCT), expression plasmid transfer, and sequence analysis that NHEJ was defective in 
this patient as a result of a defect in the DNA-PKcs gene. The molecular basis of this IR 
hypersensitivity is due to deletion of exon 31 of the DNA-PKcs gene causing an in-frame 
deletion of 249 bp with a predicted 82 amino acid deletion from the protein. 
Our data represent the second reported case of a defective DNA-PKcs gene in 
human cells. This is also the first reported case where two distinct DNA repair pathways 
(NER and NHEJ) are defective in a single individual. These observations indicate how 
undiagnosed defects in DNA repair pathways leave patients at risk of life-threatening 
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toxicity during RT and imply the need for a simple pre-treatment screening protocol to 
identify individuals at risk. 
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Methods 
 
Cell Culture: The primary fibroblast cells lines XP14BR, MRC5, NB1 and 1BR.3 
culture conditions are described in detail elsewhere.10, 13-14 The SV40-immortalised 
fibroblast cell lines XP14BRneo17, 1BR.3-G, MRC5-SV1, GMO637 and culture 
conditions are all described elsewhere.11 Culture of the MO59J human glioblastoma cell 
line used for western blot analysis has been previously described.15 
Clonogenic Cell Survival Assays: Clonogenic cell survival assays following exposure to 
γ-radiation (from a 60Cobalt source) were conducted as previously described.11, 13  
Microcell Mediated Chromosome Transfer: MMCT was performed as described 
elsewhere.16 Briefly, A9:monochromosome donor hybrids were exposed to 75-100 ng/ml 
colcemid (Sigma, Dorset, UK) for 48 h to induce metaphase arrest and micronucleation. 
After a 5 minute incubation in serum free medium containing 10 μg/ml cytochalasin B 
(Sigma) micronuclei were harvested by centrifugation at 4500 rpm for 15 min at room 
temperature and purified by successive filtration through 8, 5 and 3 μm polycarbonate 
filters (Whatman, Kent, UK). Purified micronuclei were fused to recipient cells in the 
presence of 100 µg/ml phytohaemaglutinin-B, 10% dimethyl sulfoxide and polyethylene 
glycol (Sigma) for one minute. Selection of monochromosome hybrids of XP14BRneo17 
was performed 48 hrs later by incubating the cells in the presence of 150 μg/ml 
hygromycin B (Merck Chemicals Ltd, Nottingham, UK). After 3 weeks, hygromycin B 
resistant colonies were isolated. 
γ-Irradiation Pre-Screen of XP14BRneo17 Monochromosome Hybrids:  To identify 
chromosomes which functionally corrected the IR hypersensitivity of XP14BRneo17 
cells; hybrids were exposed to 2 Gy γ-radiation. Five thousand cells were plated, and the 
number of colonies formed after three weeks were expressed as a percentage of colonies 
formed from non  γ-irradiated cells. Survival of XP14BRneo17 monochromosome 
hybrids at 2 Gy was compared with that of XP14BRneo17 parental cells and the repair 
normal cell line 1BR.3-G.  
cDNA Transfection: The cDNA expression constructs of DNA-PKcs and Ku80 were a 
kind gift from Dr. David Chen (Department of Radiation Oncology, University of Texas 
Southwestern Medical Center, Dallas, Texas, USA). The plasmid pCMPD-6 utilizing the 
cytomegalovirus (CMV) promoter contained a full length human DNA-PKcs cDNA. The 
pKM-A1 plasmid (under control of the CMV promoter) contained a full length DNA-
PKcs cDNA with an inactivating missense lysine to arginine mutation at amino acid 3752 
in the serine threonine kinase domain of the protein.17 The Ku80 cDNA was provided in 
the pIREShyg2 plasmid (BD Biosciences, Cowley, Oxford, UK) with gene expression 
under the control of the CMV promoter. 
Transfection of XP14BRneo17 cells with the DNA-PKcs or Ku80 expression 
plasmids was performed using calcium phosphate co-precipitation.17 The pCMPD-6 and 
pKM-A1 plasmids with the DNA-PKcs cDNA were co-transfected with the pPur plasmid 
(Clontech, Hants, UK) conferring resistance to the antibiotic puromycin. 15 μg of each 
plasmid was added to the cells for 24 hrs after which cells were selected in 100 ng/ml 
puromycin for 4 weeks. For pIREShyg2-Ku80 plasmid transfections cells were selected 
in 150 unit/ml hygromycin B.  
Detection of γ-H2AX Foci – Immunofluorescence Assay: Detection of nuclear γ-
H2AX foci following 2 Gy irradiation (at 0, 1, 5, 7, 9 and 24 h) was performed according 
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to the method described previously.18 Anti phospho-serine139 γ-H2AX monoclonal 
antibody (Upstate Biochemicals, Hampshire, UK) at 1:10,000 dilution was added for 1 h 
at room temperature. Alexa Fluor® 488 goat anti-mouse IgG antibody diluted 1:1000 
was added to the cells for 1 h (Molecular Probes, Paisley, UK) after which they were 
counterstained with 2 µg/ml of propidium iodide in PBS and mounted in Vectashield® 
(Vector Laboratories, Peterborough, UK). Analysis was performed by counting the 
number of foci in a minimum of 100 nuclei of each cell line per time point using a 
fluorescence microscope. Results are expressed as the percentage of γ-H2AX positive 
cells containing 5 or more γ-H2AX foci since untreated cells typically exhibited 0 -2 foci 
per cell. 
Western Blot Analysis: Protein extracts of XP14BR, MRC5, 1BR.3 primary human 
fibroblast and MO59J human glioblastoma cell line, derived from 2x105 cells were 
separated by SDS-PAGE using a 4-15% gradient gel (Biorad Laboratories Ltd, Herts. 
UK). Proteins of interest were detected by western blotting using a mouse anti-human 
DNA-PKcs monoclonal antibody (Lab Vision, Freemont, CA, USA) or human β-actin as 
a loading control (Abcam PLC, Cambridge, UK) and proteins visualised by 
chemiluminescence. 
DNA Sequence Analysis of the DNA-PKcs Coding Region: Total RNA was isolated 
from primary XP14BR cells using TriZol reagent (Sigma). cDNA was synthesised from 
total RNA using random primers and Superscript III reverse transcriptase (InVitrogen, 
Paisley, Scotland). The DNA-PKcs cDNA sequence from XP14BR encompassing 12,291 
base pairs (bp) was constructed in a contig of 17 fragments between 800-1000 bp in size 
using gene specific primers by PCR. Each amplified fragment overlapped by 
approximately 100 bp. cDNA fragments were cloned into the pCR-4-Topo sequencing 
vector (InVitrogen). Four individual clones of each fragment of DNA-PKcs from 
XP14BR cells were subjected to DNA sequence analysis on both the coding and non-
coding strand. 
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Results 
                The dose required to reduce clonogenic cell survival to 10% in immortalised 
DNA repair normal cell lines, 1BR.3-G, MRC5-SV1 and GM0637 was 3.5, 4.8 and 4.8 
Gy respectively. For the XP14BRneo17 cell line, 1.4 Gy reduced the clonogenic survival 
to 10% (Figure 1). Hence XP14BRneo17 cells were 2.5 - 3.4 fold more sensitive to the 
lethal effects of γ-irradiation than the three normal cell lines tested. 
               Normal copies of 6 individual human chromosomes harbouring NHEJ genes 
required for DSB repair were individually transferred to XP14BRneo17 cells (Table 1) 
and screened for radiation sensitivity after exposure to 2 Gy γ-irradiation (Figure 2A).  In 
all radiation sensitive hybrids and in XP14BRneo17 cells the cell survival was 
approximately 10% or less. Transfer of chromosome 8 in one hybrid (Chr.8C) resulted in 
46% cell survival in line with the level of cell survival expected in the repair normal cell 
line 1BR.3-G.  That only 1 hybrid containing chromosome 8 corrected the radiation 
sensitivity phenotype is consistent with previous findings where only a small proportion 
of hybrids exhibit functional complementation.16 The prolonged colcemid exposure 
during MMCT to induce micronucleation introduces small intrachromosomal deletions in 
donor chromosomes which often encompass key loci, which in these experiments could 
include the large DNA-PKcs genomic sequence (approximately 200 Kb). Complete 
clonogenic survival assays showing a normal cell survival response of hybrid Chr.8C 
similar to the repair normal 1BR.3-G, MRC5-SV1 and GM0637 cells are presented in 
figure 2B. Since chromosome 8 (8q11) contains the DNA-PKcs gene required for NHEJ 
this provided evidence that a mutation in DNA-PKcs may account for the clinical and 
cellular radiosensitivity of this patient.  
 
 
 Table 1: A list of chromosomes containing genes involved in NHEJ together with 
the number of hybrids derived from each MMCT experiment.  
 
Donor Cell 
Line 
NHEJ  Repair 
Gene 
Number of 
Monochromosome 
Hybrids Isolated 
Number of IR Resistant 
Hybrids (2 Gy) 
A9-Chr. 2 Ku80 and 
Cerrnunos-XLF 
7 0 
A9-Chr. 5 XRCC4 6 0 
A9-Chr. 8 DNA-PKcs 6 1 
A9-Chr.10 Artemis 3 0 
A9-Chr.13 Ligase IV 5 0 
A9-Chr.22 Ku70 8 0 
  
  XP14BRneo17 cells were transfected with an expression plasmid containing the 
DNA-PKcs cDNA (pCMPD-6). As a control, XP14BRneo cells were also transfected 
with an expression plasmid containing a non-functional mutation in the kinase domain of 
the DNA-PKcs cDNA (pPKM-A1). Figure 3A demonstrates that two clones of 
XP14BRneo17 transfected with pCMPD-6 had a normal clonogenic cell survival 
response.  XP14BRneo17 cells transfected with the mutated DNA-PKcs cDNA or the 
Ku80 cDNA remained radiation sensitive. Restoration of a normal IR response by DNA-
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PKcs transfection in XP14BRneo 17 cells was associated with efficient DNA DSB repair, 
measured by the induction and removal of γ-H2AX foci in the nuclei of cells irradiated 
with 2 Gy γ-radiation. Representative examples of γ-H2AX foci staining are shown in 
Figure 3B.  Immediately after γ-irradiation, over 80% of all cells had 5 or more γ-H2AX 
foci. Figure 3C demonstrates that the normal level of radiosensitivity exhibited by 
transfection of XP14BRneo17 cells with the DNA-PKcs cDNA is associated with the 
removal of γ-H2AX foci similar to the normal fibroblasts MRC5-SV1 and GM0637. 
After 24 hours 65.5% of XP14BRneo17 cells retained 5 or more γ-H2AX foci. Also,  
XP14BRneo17 cells  transfected with the mutated DNA-PKcs or the Ku80 cDNA, 
70.11% and 76.20% of nuclei scored positive for γ-H2AX foci after 24 hours. Two clones 
of XP14BRneo17 cells transfected with normal DNA-PKcs showed a reduction of 
positive nuclei to 12.3% and 18.6% respectively after 24 hours which was similar to the 
normal MRC5-SV1 and GMO636 cell lines.  
 We then investigated whether the DNA-PKcs protein was produced in the 
XP14BR cells. DNA-PKcs protein expression levels in XP14BR, MRC-5, 1BR.3 and 
MO59J cells detected by western blot are shown in Figure 4. In XP14BR cells, a protein 
that co-migrates with full length DNA-PKcs protein is expressed when compared to DNA 
repair normal MRC-5 and 1BR.3 cells. However, taking into account the mass of the 
DNA-PKcs protein (470 kDa), it was not possible to detect small in-frame deletions by 
western blotting. A band could not be detected in the MO59J cells consistent with a 
deletion of DNA-PKcs in this repair defective cell line.15 
  To identify the mutation, extensive DNA sequence analysis of 136 cloned 
fragments (4 independent clones of each of the 17 fragments sequenced on the sense and 
antisense strand) of the cDNA contig of DNA-PKcs of XP14BR revealed a 249 bp in-
frame deletion between bp 3656-3904 encompassing the entire exon 31 resulting in a 
predicted 82 aa residue deletion. This was observed in 3 of the 4 independent clones 
sequenced. The location of this deletion within the context of the DNA-PKcs coding 
sequence is shown in figure 5. To identify what would cause the exon skipping we 
sequenced the genomic DNA surrounding exon 31. Sequencing of the surrounding 
intron:exon junctions including 250 bp intronic DNA either side of exon 31 in genomic 
DNA did not reveal a splicing mutation. To confirm these observations the cDNA 
encompassing this region was sequenced from second independent isolate of RNA from 
XP14BR cells and the exon 31 deletion was observed in 2 of 4 clones. Sequence analysis 
of cDNA encompassing exons 30 to 32 of DNA-PKcs from two normal cell lines (1BR.3 
and NB1: 4 independent cloned fragments from each cell line) revealed no such deletion.  
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Discussion 
 
In this study we report a primary defect in the DNA-PKcs gene in normal (non-
tumour) tissue from a human patient. DNA-PKcs is an essential genetic component in the 
repair of ionising radiation-induced DNA DSB via the NHEJ pathway The DNA-PK 
complex consists of Ku70/80 heterodimer and a 470kDa catalytic subunit DNA-PKcs 
with serine-threonine kinase activity. DNA-PKcs binds to DNA ends in a Ku80 
dependent manner, to initially suppress efficient ligation of DNA ends. DNA-PKcs 
autophosphorylation then liberates the DNA ends of the strand break allowing ligation by 
the ligase IV-XRCC4 protein complex. It is speculated that DNA-PKcs acts as a 
molecular “gatekeeper” preventing premature ligation of DNA ends.19 
Animal models have demonstrated that defects in any component of NHEJ 
(including DNA-PKcs) can lead to hypersensitivity to IR, genome instability, 
immunodeficiency and cancer.4 Until recently, in humans, only two of these genes, ligase 
IV and Artemis have been linked to a predisposition for lymphoma or leukaemia and to 
extreme radiosensitivity.5-6  The first report that mutations in the DNA-PKcs gene can 
result in radiosensitivity and severe combined immunodeficiency (SCID) involved a 
patient with a missense mutation in the DNA-PKcs gene (L3062R) causing an inability to 
activate Artemis leading to defective NHEJ.20  
To define the molecular defect in DNA-PKcs in XP14BR cells, western blot 
analysis (Figure 4) indicated that a protein indistinguishable in length from the DNA-
PKcs protein was detectable, when compared to the normal 1BR.3 and MRC5 cells. This 
data suggested that it was unlikely that a large structural deletion in the DNA-PKcs gene 
was responsible for the defective function of the protein.  DNA sequence analysis of the 
DNA-PKcs cDNA in XP14BR revealed a 249 bp deletion of the entire exon 31 of the 
transcript resulting in a predicted 82 aa deletion.  In two normal cell lines (1BR.3 and 
MRC5) exon 31 was retained in the full length transcript. Analysis of the intron:exon 
boundaries of exon 31 did not reveal a splicing mutation.  
There are two possibilities why this splicing defect might cause the 
radiosensitivity in XP14BR cells. Firstly, the patient is heterozygous and therefore haplo-
insufficient for the DNA-PKcs protein, however, we did not identify any genomic 
mutation causing the splicing abnormality in the DNA-PKcs coding sequence.  Secondly, 
we have identified a novel splicing isoform of DNA-PKcs (EX31) which is expressed in 
the XP14BR patient and the EX31 protein is acting as a dominant negative mutant.  
The functional consequences of the predicted 82 aa deletion from the protein are 
summarised in figure 5. Multiple sequence alignments 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml) and structural analysis 
(http://www.ics.uci.edu/~baldig/) indicate that the 82 aa sequence encoded by exon 31, could 
be folded into an α-helix. Conservation of amino acid residues between species indicate 
that the region could play an important role maintaining protein structure.  
The deletion of an entire exon without an apparent splicing mutation is not 
normally considered to be an unusual observation. For DNA-PKcs, at least three 
conserved splice variants including a full length transcript (variant I); a transcript which 
retains an intron between exon 82 and 83 (variant II) and a transcript in which exon 80 is 
deleted (variant III) are observed.21  
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Pre-mRNA splicing is an essential step in the expression of almost all eukaryotic 
genes, and alternative splicing appears to be the mechanism responsible for the 
generation of up to 75% of the human proteome. There are different modes of alternative 
splicing, however the differential inclusion or exclusion of an exon or group of exons, so 
called cassette-exon, is the most common type of alternative splicing event.22  
In summary, we conclude that the deletion of exon 31 of DNA-PKcs gene in the 
XP14BR patient represents a novel isoform of the DNA-PKcs gene whose expression is 
associated with the clinical and cellular IR hypersensitivity. Interestingly, 
immunodeficiency, often observed with human defects of NHEJ was not observed in this 
patient23. We provide only the second reported case of an individual with a primary 
defect in the DNA-PKcs gene, but the first report of an individual with DNA repair 
defects in two independent pathways, NHEJ and NER.  
 Finally, these data show how seemingly “mild” or undiagnosed defects in DNA 
repair factors, while consistent with viability, can have catastrophic consequences should 
such an individual require cytotoxic anticancer RT. Simple pre-treatment screening 
protocols such as measuring the induction of repair of nuclear γ-H2AX foci in patient 
cells24,  to identify individuals at risk would increase the safety of RT for such 
individuals. 
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Figure Legends 
Figure 1: The clonogenic cell survival of XP14BRneo17 compared to MRC5-SV1, 
GM0637 and 1BR.3-G following exposure to increasing doses γ-radiation is shown (refer 
to key for cell line identification). The error bars represent the standard error of the mean 
response derived from three independent experiments. 
Figure 2A: The clonogenic cell survival following exposure to 2 Gy γ-radiation of 
XP14BRneo17-monochromosome hybrids, parental XP14BRneo17 cells and repair 
normal 1BR.3-G cells is shown. The hybrid of chromosome 8 functionally correcting the 
IR hypersensitivity of XP14BRneo17 cells is indicated as Chr.8 C. 
Figure 2B: The clonogenic cell survival of XP14BRneo17 compared to MRC5-SV1, 
GM0637 and 1BR.3-G and hybrids of XP14BRneo17 cells containing an additional 
human chromosome 8, following exposure to increasing doses γ-radiation is shown (refer 
to key for cell line identification). The chromosome 8 hybrid exhibiting a corrected IR 
response is referred to as Chr.8 C. The error bars represent the standard error of the mean 
response derived from three independent experiments. 
Figure 3A: The clonogenic cell survival of XP14BRneo17 compared to MRC5-SV1, 
GM0637 and 1BR.3-G and XP14BRneo17 cells following transfection with a full length 
DNA-PKcs cDNA (pCMPD-6 clones 1 and 2) or a DNA-PKcs cDNA with a mutation in 
the kinase domain (pPKM-A1, clones 1 and 2) and XP14BRneo17 cells transfected with 
the Ku80 cDNA, following exposure to increasing doses γ-radiation is shown (refer to 
key for cell line identification). The error bars represent the standard error of the mean 
response derived from three independent experiments. 
Figure 3B: A representative image of γ-H2AX foci in the nuclei of XP14BRneo 17 and a 
clone of XP14BR neo17 transfected with the DNA-PKcs cDNA expression plasmid 
pCMPD-6 (clone 1) following exposure to 2 Gy γ-irradiation.  
Figure 3C: The induction and repair over a 24 hr period of 2 Gy γ-radiation induced γ-
H2AX foci in the nuclei of irradiated cells. MRC5-SV1 and GMO637 are repair normal 
cell lines. The IR hypersensitive XP14BRneo17 parental cell line is compared with 
XP14BRneo17 cells transfected with either pCMPD-6 (normal DNA-PKcs) or pPKM-A1 
(mutated DNA-PKcs) and pIREShyg2-Ku80 (normal Ku80 cDNA). Error bars represent 
the standard error of the mean of two independent experiments for each cell line. 
Figure 4  
Panel A: Western blot analysis of DNA-PKcs protein expression in primary XP14BR 
compared with repair normal MRC-5 and 1BR.3 human fibroblasts and DNA-PKcs 
defective MO59J human glioblastoma cell line.  
Panel B: As a loading control, Human β-actin expression in each cell type was also 
examined. 
Figure 5 
Schematic view of the DNA-PKcs protein.  Functional domains, identified from the pfam 
database (http://pfam.sanger.ac.uk/), and the location of exon 31 are highlighted. 
Comparisons to the DNA-PKcs protein sequences (NCBI) from other species from within 
the exon 31 region are shown in an expanded view.  Boxed sequences highlight 
evolutionary conserved residues. 
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